drugset / Trial / NCT05570669

Summary

Multicenter, prospective, randomized, checked, open label, with blind evaluation, for compare the intestinal cleansing effectiveness of the regimen full-dose delayed (A) of Clensia vs split regimen (B) of Clensia, in patients undergoing endoscopy.

Timeline

Start
2021-05-25
Primary completion
2021-12-28
Completion
2021-12-28

Drugs

EvaluationDrugModalityDoseRoute
Subject PEG 4000 Unknown 52.5 g
Subject Simethicone Other / unclassified 0.08 g
Subject Sodium sulphate anhydrous Unknown 3.75 g

Indications

No indication recorded.